Several studies have revealed that TAMs induce tumor chemoresistance through various mechanisms, and mammary tumors reduce the therapeutic response to anti-cancer drugs through mechanisms, such as IL-10/STAT3/Bcl2 signaling12,24,25. This evidence concerns the gene STAT3 and breast cancer.